Search
for
Sort by
Research 91–120 of 108
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- Adolopment of clinical practice guidelines and creation of referral pathways for dermatological conditions in Pakistan
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- The Role of Extracellular Vesicles in the Development and Treatment of Psoriasis: Narrative Review
- Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
- Severe pityriasis rubra pilaris complicated with Kaposi's varicelliform eruption and cutaneous MRSA infection case report
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Prevalence of hirsutism in Turkey: Data of the dermatoendocrinology study group
- Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
- Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns
- Conference 2022, The Sequel
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Cicatricial alopecia/lichen planopilaris-the Cleveland clinic foundation experience on evaluation, diagnosis and treatment
- Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab
- Hair whitening in a patient with psoriasis on adalimumab reversed after switching to ixekizumab
- 41824 Palmoplantar psoriasis complete clearance is achieved rapidly and sustained with ixekizumab treatment in adult and pediatric patients with moderate-to-severe plaque psoriasis
- Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib
- Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up
- 42276 Long-Term Safety of Ixekizumab Treatment in Adult Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: A Post-hoc Analysis of End-Of-Study Program Data Relating to Major Adverse Cardiovascular Events
- LB1667 Successful treatment of rare linear lichen planopilaris with ixekizumab
- Successful treatment of rare linear lichen planopilaris with Ixekizumab
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- New developments in the molecular treatment of ichthyosis: review of the literature